Related references
Note: Only part of the references are listed.Summary measure of discrimination in survival models based on cumulative/dynamic time-dependent ROC curves
Jerome Lambert et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Assessing Prognostic Significance of Preoperative Alpha-Fetoprotein in Hepatitis B-Associated Hepatocellular Carcinoma: Normal is not the New Normal
Sima Blank et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Combination of Osteopontin with Peritumoral Infiltrating Macrophages is Associated with Poor Prognosis of Early-Stage Hepatocellular Carcinoma after Curative Resection
Wenwei Zhu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Meta-Analysis of the Prognostic and Diagnostic Significance of Serum/Plasma Osteopontin in Hepatocellular Carcinoma
JiWen Cheng et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma
Takashi Kumada et al.
JOURNAL OF GASTROENTEROLOGY (2014)
A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
Mengjun Wang et al.
BMC MEDICAL GENOMICS (2013)
Myeloid Differentiation Factor 88 Promotes Growth and Metastasis of Human Hepatocellular Carcinoma
Beibei Liang et al.
CLINICAL CANCER RESEARCH (2013)
Extended Postinterventional Tumor Necrosis-Implication for Outcome in Liver Transplant Patients with Advanced HCC
Arno Kornberg et al.
PLOS ONE (2013)
Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma
Yang Lei et al.
SCIENCE CHINA-LIFE SCIENCES (2013)
Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
Shun-Jun Fu et al.
SURGERY (2013)
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
Tao Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
Akihiko Osaki et al.
CANCER MEDICINE (2013)
Pilot Study on Pericytic Mimicry and Potential Embryonic/Stem Cell Properties of Angiotropic Melanoma Cells Interacting with the Abluminal Vascular Surface
Claire Lugassy et al.
CANCER MICROENVIRONMENT (2013)
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
Wing-Kin Syn et al.
GUT (2012)
Identification of osteopontin as a novel marker for early hepatocellular carcinoma
Sufen Shang et al.
HEPATOLOGY (2012)
Tiam1-regulated osteopontin in senescent fibroblasts contributes to the migration and invasion of associated epithelial cells
Jiewei Liu et al.
JOURNAL OF CELL SCIENCE (2012)
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
Qiujin Shen et al.
LANCET ONCOLOGY (2012)
The ovarian cancer-derived secretory/releasing proteome: A repertoire of tumor markers
Ying Zhang et al.
PROTEOMICS (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively
Masahiro Kobayashi et al.
HEPATOLOGY RESEARCH (2011)
Pregnancy-specific Glycoprotein 1 Induces Endothelial Tubulogenesis through Interaction with Cell Surface Proteoglycans
Felipe A. Lisboa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria
Wolfgang Sieghart et al.
JOURNAL OF HEPATOLOGY (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
Yilei Mao et al.
GUT (2010)
The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma
Jian Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection
Rong-Xin Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
A Novel Nonsynonymous Variant of Matrix Metalloproteinase-7 Confers Risk of Liver Cirrhosis
Tzu-Min Hung et al.
HEPATOLOGY (2009)
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
Jaw-Ching Wu et al.
JOURNAL OF HEPATOLOGY (2009)
Recurrence of Hepatocellular Carcinoma
Morris Sherman
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma
Kazuaki Shimada et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers
Ryosuke Tateishi et al.
HEPATOLOGY (2006)
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma
Hui Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
An approach to studying lung cancer-related proteins in human blood
T Xiao et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Differential gene expression profile reveals deregulation of pregnancy specific β1 glycoprotein 9 early during colorectal carcinogenesis -: art. no. 66
S Salahshor et al.
BMC CANCER (2005)
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
LX Qin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Osteopontin induces nuclear factor κB-mediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways
S Philip et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
